Qilong Wang

机构：Shenyang Pharmaceutical University, Jiangsu University, Tianjin University of Traditional Chinese Medicine, Shandong University, Xuzhou Medical College, Anhui University of Science and Technology, Huaian First People’s Hospital, Second People’s Hospital of Huai’an, Jiangsu Food and Pharmaceutical Science College, Jiangsu Education Department, Huainan Mining Industry Group (China), Jiangsu Provincial Hospital of Traditional Chinese Medicine, Food Research and Development Institute, Nanjing Medical University · ORCID：0000-0002-5116-9186

发表论文 98 篇 · 总被引 2405 次 · h-index 26

代表论文

• Partial‐Oxidation Enabling Homologous Ru/RuO 2 Heterostructures With Proper d‐Dand Center as Efficient and Durable Cathode Catalysts for Ultralong Cycle Life in Li–O 2 Batteries (2024 · Advanced Energy Materials · 被引 22)
• Microfluidic fabricated bisdemethoxycurcumin thermosensitive liposome with enhanced antitumor effect (2023 · International Journal of Pharmaceutics · 被引 19)
• Folic acid conjugated palygorskite/Au hybrid microgels: Temperature, pH and light triple-responsive and its application in drug delivery (2023 · Colloids and Surfaces B Biointerfaces · 被引 18)
• Paclitaxel/Luteolin Coloaded Dual‐Functional Liposomes for Esophageal Cancer Therapy (2025 · Advanced Science · 被引 17)
• Development of a Specific Aptamer‐Modified Nano‐System to Treat Esophageal Squamous Cell Carcinoma (2024 · Advanced Science · 被引 17)
• Mori fructus-derived extracellular vesicle-like nanoparticles regulate dyslipidemia and prevent atherosclerosis progression via miRNAs (2025 · Phytomedicine · 被引 13)